Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hebert

Showing results (401-410 of 460) with videos related to

Pageof 46
Sort By:
The Journal of Dermatological Treatment|May 12, 2024
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trialsAdelaide A Hebert, Carsten Flohr, H Chih-Ho Hong, et al.
Nephron. Clinical Practice|July 16, 2011
Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicatedChadwick E Barnes, William A Wilmer, Raul A Hernandez, et al.
Kidney International|July 4, 2008
Biomarkers of lupus nephritis determined by serial urine proteomicsXiaolan Zhang, Ming Jin, Haifeng Wu, et al.
Journal of the American College of Cardiology|April 20, 2004
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaBernard R Chaitman, Sandra L Skettino, John O Parker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 4, 1999
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril StudyW A Wilmer, L A Hebert, E J Lewis, et al.
Kidney International Reports|August 13, 2021
The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its FlareChris R Toy, Huijuan Song, Haikady N Nagaraja, et al.
Molecular Imaging and Biology|December 27, 2023
Neoadjuvant Therapies Do Not Reduce Epidermal Growth Factor Receptor (EGFR) Expression or EGFR-Targeted Fluorescence in a Murine Model of Soft-Tissue SarcomasSamuel S Streeter, Xiaochun Xu, Kendra A Hebert, et al.
Molecular Immunology|November 27, 2012
Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosusNicholas A Young, Alexandra K Friedman, Benjamin Kaffenberger, et al.
Proceedings of Spie--The International Society for Optical Engineering|April 3, 2023
First demonstration of a novel nerve-targeting fluorophore in a cohort of <i>ex vivo</i> human tissuesKendra A Hebert, Logan Bateman, Dylan Parker, et al.
Advances in Experimental Medicine and Biology|August 9, 2006
Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjectsYee-Ling Wu, Gloria C Higgins, Robert M Rennebohm, et al.
Pageof 46

Showing results (401-410 of 460) with videos related to

Sort By:
Pageof 46
The Journal of Dermatological Treatment|May 12, 2024
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trialsAdelaide A Hebert, Carsten Flohr, H Chih-Ho Hong, et al.
Nephron. Clinical Practice|July 16, 2011
Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicatedChadwick E Barnes, William A Wilmer, Raul A Hernandez, et al.
Kidney International|July 4, 2008
Biomarkers of lupus nephritis determined by serial urine proteomicsXiaolan Zhang, Ming Jin, Haifeng Wu, et al.
Journal of the American College of Cardiology|April 20, 2004
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaBernard R Chaitman, Sandra L Skettino, John O Parker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 4, 1999
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril StudyW A Wilmer, L A Hebert, E J Lewis, et al.
Kidney International Reports|August 13, 2021
The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its FlareChris R Toy, Huijuan Song, Haikady N Nagaraja, et al.
Molecular Imaging and Biology|December 27, 2023
Neoadjuvant Therapies Do Not Reduce Epidermal Growth Factor Receptor (EGFR) Expression or EGFR-Targeted Fluorescence in a Murine Model of Soft-Tissue SarcomasSamuel S Streeter, Xiaochun Xu, Kendra A Hebert, et al.
Molecular Immunology|November 27, 2012
Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosusNicholas A Young, Alexandra K Friedman, Benjamin Kaffenberger, et al.
Proceedings of Spie--The International Society for Optical Engineering|April 3, 2023
First demonstration of a novel nerve-targeting fluorophore in a cohort of <i>ex vivo</i> human tissuesKendra A Hebert, Logan Bateman, Dylan Parker, et al.
Advances in Experimental Medicine and Biology|August 9, 2006
Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjectsYee-Ling Wu, Gloria C Higgins, Robert M Rennebohm, et al.
Pageof 46